Evidence map›Paper›PMID 26607224›Full record

ArticleBMC infectious diseases2015

Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methods.

Felipe A Castro, Jill Koshiol, Wim Quint, Cosette M Wheeler, Maura L Gillison, Laurence M Vaughan, Bernhard Kleter, Leen-Jan van Doorn, Anil K Chaturvedi, Allan Hildesheim and 6 more

Open access · goldAbstract readComparative StudyEvaluation Study
In one paragraph

Article in BMC infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Oral HPV prevalence assessment by Linear Array vs. SPFPapillomavirus research (Amsterdam, Netherlands) · 2020
    Article
  10. A fluorometric hybridization assay for detecting and genotyping high-risk human papillomavirus 16 and 18 in archival tissues of cervical specimens.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 2 countries.

Felipe A CastroDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. f.castro@Dkfz-Heidelberg.de.
Jill KoshiolDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. koshiolj@mail.nih.gov.
Wim QuintDDL, Diagnostic Laboratory, Rijswijk, The Netherlands. wim.quint@ddl.nl.
Cosette M WheelerDepartment of Pathology, School of Medicine, University of New Mexico, Albuquerque, NM, USA. CWheeler@salud.unm.edu.
Maura L GillisonViral Oncology Program, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. Maura.Gillison@osumc.edu.
Laurence M VaughanBD Diagnostics, Sparks, MD, USA. laurence_vaughan@bd.com.
Bernhard KleterDDL, Diagnostic Laboratory, Rijswijk, The Netherlands. Bernhard.Kleter@ddl.nl.
Leen-Jan van DoornDDL, Diagnostic Laboratory, Rijswijk, The Netherlands. L.J.van.Doorn@ddl.nl.
Anil K ChaturvediDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. chaturva@mail.nih.gov.
Allan HildesheimDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. hildesha@exchange.nih.gov.
Mark SchiffmanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. schiffmm@exchange.nih.gov.
Sophia S WangDivision of Cancer Etiology, Department of Population Sciences, Beckman Research Institute and the City of Hope, Duarte, CA, USA. sowang@coh.org.
Rosemary E ZunaDepartments of Pathology and Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. rosemary-zuna@ouhsc.edu.
Joan L WalkerDepartments of Pathology and Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. joan-walker@ouhsc.edu.
S Terence DunnDepartments of Pathology and Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Terence-Dunn@ouhsc.edu.
Nicolas WentzensenDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. wentzenn@mail.nih.gov.
DDL Diagnostic Laboratory · NLDivision of Cancer Epidemiology and GeneticsNational Cancer Institute · USUniversity of Oklahoma Health Sciences Center · USAdvanced Cell Diagnostics (United States) · USCity of Hope · USThe Ohio State University · USUniversity of New Mexico · US

Funding

Human papillomavirus (HPV) infection and cervical and anal cancersZIACP010124 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI WENTZENSEN, NICOLAS · 2009 to 2025
$17.3M
The EPI-STI Biostatistics and Bioinformatics Core (Cuzick/Wheeler)U19AI113187 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI WHEELER, COSETTE MARIE · 2014 to 2018
$12.6M
CERVICAL CANCER AND HUMAN PAPILLOMAVIRUS (HPV) INFECTIONZ01CP010124 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI SCHIFFMAN, MARK · 1996 to 2008
$3.0M
CLINICAL/IMMUNOLOGIC/GENETIC ANALYSES OF AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROMEZ01AI000732 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI RAO, VEMULKONDA · 1995 to 2008
$1.1M
Intramural NIH HHS Z01 CP010124NIAID NIH HHS U19 AI113187
6 · The paper itself

Abstract

backgroundIdentification of human papillomavirus (HPV) DNA in cervical tissue is important for understanding cervical carcinogenesis and for evaluating cervical cancer prevention approaches. However, HPV genotyping using formalin-fixed, paraffin-embedded (FFPE) tissues is technically challenging. We evaluated the performance of four commonly used genotyping methods on FFPE cervical specimens conducted in different laboratories and compared to genotyping results from cytological samples.

methodsWe included 60 pairs of exfoliated-cell and FFPE specimens from women with histologically confirmed cervical intraepithelial lesions grade 2 or 3. Cytology specimens were genotyped using the Linear Array assay. Four expert laboratories processed tissue specimens using different preparation methods and then genotyped the resultant sample preparations using four different HPV genotyping methods: SPF10-PCR DEIA LiPA25 (version 1), Inno-LiPA, Linear Array and the Onclarity assay. Percentage agreement, kappa statistics and McNemar's chi-square were calculated for each comparison of different methods and specimen types.

resultsOverall agreement with respect to carcinogenic HPV status for FFPE samples between different methods was: 81.7, 86.7 and 91.7% for Onclarity versus Inno-LiPA, Linear Array and SPF-LiPA25, respectively; 81.7 and 85.0% for Linear Array versus Inno-LiPA and SPF-LiPA25, respectively; and 86.7% for SPF-LiPA25 versus Inno-LiPA. Type-specific agreement was >88.3% for all pair-wise comparisons. Comparisons with cytology specimens resulted in overall agreements from 80 to 95% depending on the method and type-specific agreement was >90% for most comparisons.

conclusionsOur data demonstrate that the four genotyping methods run by expert laboratories reliably detect HPV DNA in FFPE specimens with some variation in genotype-specific detection.

Indexed as

Genotyping TechniquesParaffin EmbeddingAdultCervix UteriDNA, ViralFemaleGenotypeHumansMiddle AgedMolecular TypingPapillomaviridaePolymerase Chain ReactionSpecimen HandlingUterine Cervical DysplasiaUterine Cervical NeoplasmsDNA, Viral

Identifiers

PMID26607224
PMCPMC4660657
OpenAlexW2248815510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.